false 0000799698 0000799698 2024-10-04 2024-10-04 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 4, 2024

 

LADRX CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware   000-15327   58-1642740

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

11726 San Vicente Boulevard, Suite 650

Los Angeles, California 90049

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (310) 826-5648

 

Former name or former address, if changed since last report: None

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(g) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share Series B Junior Participating Preferred Stock Purchase Rights   LADX   OTC Markets

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

2024 Annual Meeting Results

 

On October 4, 2024, LadRx Corporation (the “Company”) held its 2024 Annual Meeting of Stockholders (the “Annual Meeting”). As of the close of business on August 9, 2024, the record date for the Annual Meeting, there were 495,092 shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”), outstanding and entitled to vote on the proposals described below. The matters described below were submitted to a vote of the Company’s stockholders at the Annual Meeting.

 

At the beginning of the Annual Meeting, there were 265,104 shares of Common Stock present at the Annual Meeting in person or by proxy, which represented 53.54% of the outstanding shares of Common Stock entitled to vote at the Annual Meeting and which constituted a quorum for the transaction of business.

 

Jennifer Simpson, Ph.D. the one director nominee, was elected and each other matter submitted to a vote of the Company’s stockholders at the Annual Meeting, as described below, was approved by the requisite vote of the Company’s stockholders. The final voting results for each of the proposals submitted to a vote of the stockholders of the Company at the Annual Meeting are set forth below. The proposals are described in detail in the Company’s definitive proxy statement (the “Proxy Statement”) filed with the Securities and Exchange Commission on August 20, 2024, and are incorporated herein by reference.

 

1. The election of one director, Jennifer Simpson, Ph.D., to serve until the 2025 Annual Meeting of Stockholders.

 

For  Against  Abstain  Broker Non-Votes
81,966  0  16,130  167,008

 

2. The ratification of the appointment of Weinberg & Company as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024.

 

For  Against  Abstain  Broker Non-Votes
226,191  36,616  2,297  -

 

3. The approval, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement.

 

For  Against  Abstain  Broker Non-Votes
79,074  18,572  450  167,008

 

For more information about the foregoing proposals, see the Proxy Statement, the relevant portions of which are incorporated herein by reference. The results reported above are final voting results. No other matters were considered or voted upon at the meeting.

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  LADRX CORPORATION
   
Date: October 9, 2024 /s/ John Y. Caloz
  John Y. Caloz
  Chief Financial Officer

 

 

 

v3.24.3
Cover
Oct. 04, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Oct. 04, 2024
Entity File Number 000-15327
Entity Registrant Name LADRX CORPORATION
Entity Central Index Key 0000799698
Entity Tax Identification Number 58-1642740
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 11726 San Vicente Boulevard
Entity Address, Address Line Two Suite 650
Entity Address, City or Town Los Angeles
Entity Address, State or Province CA
Entity Address, Postal Zip Code 90049
City Area Code (310)
Local Phone Number 826-5648
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share Series B Junior Participating Preferred Stock Purchase Rights
Trading Symbol LADX
Entity Emerging Growth Company false

LadRx (QB) (USOTC:LADX)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more LadRx (QB) Charts.
LadRx (QB) (USOTC:LADX)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more LadRx (QB) Charts.